PDL BioPharma (United States)

PDL BioPharma (United States)

PDL BioPharma is a publicly traded American holding company that since 2008 manages patents and other intellectual property that had been generated by the company. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for PDL BioPharma (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

50%


Total
Publications

221


Total Open
Publications

110


Total
Citations

22K


Open Access
Percentage

50%


Total
Publications

221


Total Open
Publications

110


Total
Citations

22K

Wikipedia

Website

download

Breakdown

20% 15% 15% 50%

Publisher Open

20%

Both

15%

Other Platform Open

15%

Closed

50%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224262830Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

4%OA Journal

OA Journal 4%

3

Hybrid 26%

20

No Guarantees 70%

54

Other Platform Open

Domain 88%

57

Institution 12%

8

Public 12%

8

Preprint 6%

4

Other Internet 5%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
58
Europe PMC
Domain
47
Figshare
Public
8
Semantic Scholar
Public
4
Kanazawa University - Kanazawa University Repository for Academic Resources (DSpace)
Institution
4
DOI
Other Internet
3
bioRxiv
Preprint
3
California Institute of Technology - CaltechAUTHORS
Institution
2
University of Twente - University of Twente Research Information
Institution
1
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
1
1 / 2

Data updated 7 October 2024

Share

Share

Share